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Genetically divergent strains of simian immunodeficiency virus (SIV) from macaques (mac), chimpanzees, and sooty
mangabeys (SM) efficiently used rhesus and human CCR5 (R5), but not CXCR4 (xR4), for cell entry. Thus far, however, no
studies have characterized primary SIVsm strains for their use of coreceptors derived from their own natural host.
Coreceptor usage of two primary, blood-derived SIVsm isolates, SIVsmSL92b and SIVsmFNS from naturally infected sooty
mangabeys, was determined. Primary SIVsm efficiently used SM-CCR5 expressed on HOS.CD4 and U87.CD4 cells. Sequence
polymorphisms in CCR5 found in four sooty mangabeys did not alter viral entry. Unlike primary rhesus blood-derived
R5-tropic SIVmac251, primary SM blood-derived R5-tropic SIVsm was strongly CD4 dependent. The SM-CXCR4 gene was
fully functional for xR4-tropic primate lentiviruses, but was not used by primary SIVsm. Therefore, the lack of xR4 tropism
among naturally occurring SIVsm strains was not due to CxCR4 gene defects in the natural host. SIVmac derived from four
macaques with AIDS also did not use macaque- or SM-derived CXCR4, showing that xR4 tropism did not develop during
progression to disease as for humans infected with HIV-1. Three of four primary HIV-2 strains used CCR5 from human, sooty
mangabey, and macaque. The fourth, HIV-27924A, obtained from a patient with AIDS, was xR4-tropic. Because SIVmac is
most closely related to HIV-2, SIVmac might be expected to mimic tropisms of HIV-2 infections. However, the correlation
between xR4 tropism and AIDS may be a species-specific phenomenon limited to humans. The R5-tropic primary SIVsm and
HIV-2 strains grew in CCR5-negative human PBMC, consistent with their use of non-CCR5 coreceptors. However, primary
SIVsmSL92b did not use non-CCR5 coreceptors efficiently. The two primary SIVsm isolates replicated poorly in CEMx174
cells, which do not express CCR5, compared to CCR5-positive PM1 cells. SIVmac grew equally well in both cell lines. The
findings show that SM-chemokine receptors are fully functional for virus entry and that multicoreceptor tropism is a common
property of primary lentiviruses within the SIVsm/HIV-2 subfamily. © 1998 Academic Press
INTRODUCTION
Shortly after the discovery of human immunodefi-
ciency virus type 1 (HIV-1), the CD4 molecule was rec-
ognized as the primary receptor for infection (Dalgleish
et al., 1984; Klatzmann et al., 1984; McDougal et al.,
1986a). HIV infection is initiated by a fusion step at the
cell surface that results from the interaction of HIV en-
velope glycoproteins and CD4 molecules (Maddon et al.,
1986; McDougal et al., 1986a). However, human CD4
molecules, when expressed on nonhuman cell lines, do
not render the cells susceptible to HIV-1 infection
(Ashorn et al., 1990; Clapham et al., 1991; Maddon et al.,
1986). Moreover, this species restriction occurs at the
level of viral entry (Broder et al., 1993; Dragic and Alizon,
1993; Dragic et al., 1992), and the entry step probably
determines the distinct tropism of HIV on human T-cell
lines and macrophages (Cheng-Mayer and Levy, 1988;
Cheng-Mayer et al., 1990). Therefore, it was proposed
over a decade ago that HIV-1 requires a cell-surface
cofactor or coreceptor other than CD4 for efficient entry
into target cells.
Such coreceptors were recently identified on CD4-bear-
ing cells (Alkhatib et al., 1996; Choe et al., 1996; Deng et al.,
1996; Doranz et al., 1996; Dragic et al., 1996). The HIV and
simian immunodeficiency virus (SIV) coreceptors belong to
the chemokine receptor family, which consists of seven
transmembrane-domain G-protein-coupled receptors. Co-
receptor usage varies with macrophage-tropic (M-tropic)
isolates of HIV-1 using CCR5 (R5), a receptor for the CC
chemokines RANTES, MIP-1a, and MIP-1b, and the T-cell-
line-adapted (TCLA) viruses using CXCR4 (xR4), a receptor
for the CXC chemokine SDF-1. These chemokines inhibit
HIV-1 infection by blocking entry (Bleul et al., 1996; Cocchi
et al., 1995; Oberlin et al., 1996). However, unlike HIV-1, most
SIV isolates studied were R5-tropic but not xR4-tropic for
entry, regardless of their cell tropism (Chen et al., 1997;
Edinger et al., 1997a). Chemokine receptors such as CCR2,
CCR3, BOB (also known as GPR15), Bonzo (or called
STRL33), GPR1, and US28 also mediate entry of some SIV
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or HIV-1 isolates (Choe et al., 1996; Deng et al., 1997;
Doranz et al., 1996; Farzan et al., 1997; Liao et al., 1997).
Sooty mangabeys (SM; Cercocebus torquatus atys)
are the natural hosts of lentiviruses within the SIVsm/
HIV-2 lineage (Chen et al., 1996; Gao et al., 1994; Hirsch
et al., 1989). Thus far, all SIVsm strains tested were
R5-tropic, whereas some TCLA HIV-2 strains were xR4-
tropic in a CD4-independent way (Endres et al., 1996;
Reeves and Schulz, 1997). However, no studies have
been done with true primary SIVsm strains that were
passaged only in sooty mangabey PBMC. To understand
the role of coreceptors on viral transmission and patho-
genesis, we characterized the CCR5 and CXCR4 genes
derived from sooty mangabeys and further compared the
coreceptor usage of primary SIVsm, HIV-2, and SIV ma-
caque (SIVmac) strains. SIVmac strains were isolated
from rhesus monkeys with AIDS. We found that (1) CCR5
and CXCR4 derived from wild sooty mangabeys facilitate
SIV and HIV infection; (2) sequence polymorphisms
found in mangabey CCR5 genes do not alter coreceptor
function; (3) CCR5 is a major coreceptor for primary
SIVsm; (4) primary SIVsm and some primary HIV-2
strains share similarities in coreceptor usage, cell tro-
pism and CD4 dependence for productive infection; and
(5) xR4 tropism is not required for AIDS development in
SIVmac-infected macaques.
RESULTS
Sooty mangabey CCR5 and CXCR4 are closely re-
lated to their respective rhesus and human genes. To
understand the role of the coreceptors CCR5 and CXCR4
in sooty mangabeys, the natural hosts of the SIVsm/
HIV-2 subfamily, CCR5 genes were cloned from cellular
DNA of four sooty mangabeys who were free-ranging in
Sierra Leone and naturally infected with SIVsm (Chen et
al., 1995, 1996). For analysis of the CXCR4 gene, cDNA
was prepared from PBMCs of an uninfected mangabey
housed at the Yerkes Regional Primate Research Center.
Nucleotide and deduced amino acid sequences were
determined for the complete coding regions of the
cloned genes. Compared to the Hu-CCR5 protein se-
quence, SM-CCR5 genes were intact in length without
the 32-bp deletion previously identified in some humans
(Liu et al., 1996). However, amino acid substitutions
N13D and V130I were found to be highly conserved in all
three nonhuman primate species: macaques, sooty
mangabeys, and chimpanzees (Fig. 1A). The four SM-
CCR5 proteins shared nine amino acid substitutions: I9T,
N13D, M49I, I52V, F78L, V130I, K171R, S180P, and P332S.
Substitutions S180P and P332S were unique in all four
sooty mangabeys, whereas the other seven substitutions
were shared with rhesus monkeys. In addition, unique
amino acid changes were found at D2E and V25G for
SM087; Y3D, M100K, V134G, and T340I for SM079; L107V
and V146L for SM089; and V146L for SM085.
Amino acid sequences deduced for a sooty mangabey
CXCR4 differed by nine positions from the human protein
(Fig. 1A). Five of the nine changes in the mangabey
sequence were shared with the CXCR4 of macaques,
including 24I, 35H, 38R, 146K, and 176S. Among another
four sites, two (32K, 148K) were shared with chimpanzee
CXCR4 and two (171G and 184F) were unique for the
mangabey studied. As we previously showed, Rh-CCR5
and Rh-CXCR4 facilitated HIV-1 infection (Chen et al.,
1997). The amino acid differences shared between sooty
mangabey and macaque, therefore, would not cause the
loss of their coreceptor function. However, the additional
amino acid substitutions could conceivably play a role in
the interactions with viral-surface proteins. A phyloge-
netic analysis using a neighbor-joining method (Saitou
and Nei, 1987) showed that SM-CCR5 and SM-CXCR4
are relatively closer to their rhesus than to their human or
chimpanzee counterparts (data not shown). They share
about 97–99% amino acid identity with their human and
rhesus counterparts.
Sooty mangabey CCR5 supports the entry of pseudo-
typed viruses bearing SIVmac and HIV-1 Envs and also
the replication of diverse SIV strains. To determine if
SM-CCR5 and SM-CXCR4 are active coreceptors, we
performed two assays as described previously (Chen et
al., 1997). First, the ability of SM-CCR5 to mediate entry of
SIVmac and NSI HIV-1 luciferase pseudoviruses was
tested. A similar amount of each luciferase reporter virus
was used to infect HOS.CD4 and U87.CD4 cells stably
expressing SM-CCR5 and SM-CXCR4 derived from five
animals. Pseudotypes bearing SIVmac and M-tropic
HIV-1 Env efficiently infected cells expressing SM-CCR5
(Fig. 2). In contrast, except for the T-tropic HIV-1 pseudo-
type, no SIV or M-tropic HIV-1 pseudotypes infected cells
expressing SM-CXCR4. Controls confirmed the appropri-
ate specificity of the cells and viruses used. Thus, SM-
CCR5 and SM-CXCR4 were active for SIVmac and HIV-1,
with a specificity similar to that of the analogous human
and rhesus coreceptors (Chen et al., 1997). Each SM-
CCR5 tested contained unique amino acid substitutions,
but the sequence polymorphism did not change their
coreceptor function.
SM-CCR5 was further tested to determine if it supported
replication by diverse SIV strains adapted to growth in a
human cell line. Coreceptor-expressing HOS.CD4 and
U87.CD4 cells were exposed to various strains of SIV. All the
SIV strains, including genetically divergent SIVsm, replicated
efficiently on HOS.CD4 and U87.CD4 cells expressing CCR5
derived from the wild-caught sooty mangabeys (Table 1). The
viruses did not discriminate among human, rhesus, or manga-
bey coreceptors. Moreover, no SIVsm replicated in cells ex-
pressing SM-CXCR4. Thus, the SIV Envs tested were highly
specific for CCR5 and did not use CXCR4 to a significant
extent, even from the natural species. These data demonstrate
that SM-CCR5 but not SM-CXCR4 functions as a coreceptor
for the simian lentiviruses tested.
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Coreceptor usage of primary SIVsm strains. In all previ-
ous studies, SIV strains were either passaged in ma-
caque species or adapted in human cell lines (Chen et
al., 1997; Edinger et al., 1997a; Marcon et al., 1997).
Therefore, it is not known which chemokine receptors
are used by primary SIVsm strains, the ancestor group
for HIV-2 (Chen et al., 1996; Gao et al., 1994). To address
this question, a primary SIVsm from a household pet
sooty mangabey was used. SIVsmSL92b is a highly di-
vergent member of the SIVsm/HIV-2 lineage but is most
closely related to HIV-2 subtype E (Chen et al., 1996).
Another primary SIVsm strain, SIVsmFNS, was used for
comparison and was isolated from a naturally infected
sooty mangabey at the Yerkes Regional Primate Center.
Like other SIV strains, primary SIVsmSL92b and
SIVsmFNS infected HOS.CD4 and U87.CD4 cells stably
expressing CCR5 but not CXCR4 from three primate
species (Tables 2 and 3). Moreover, human-derived
CCR1, CCR2b, CCR3, and CCR4 did not facilitate the
infection of SIVsmSL92b and SIVsmFNS in HOS.CD4
cells (data not shown). Table 3 shows that both primary
viruses also replicated in human ccr52/ccr52 PBMC,
which contain the delta 32-bp homozygous defect. This
replication was consistent with the findings that both
primary viruses established productive infections in
GHOS cells expressing human Bonzo and BOB. In par-
allel, SIVsm strains grown in human cells, SIVsmSL92a
and SIVsmLib-1, also used BOB and Bonzo as a core-
ceptor (Table 1). Thus, the multicoreceptor tropism is a
common property of the genetically divergent SIVsm
strains tested.
To determine whether primary viruses would repli-
cate in human cell lines, cell-free primary SIVsmSL92b
was used to infect CEMx174 and PM1 cells. By FACS
analysis using 2D7 and 12G5 monoclonal antibodies,
CEMx174 cells did not express CCR5, whereas more
FIG. 2. Entry of luciferase reporter viruses into cells expressing rhesus and sooty mangabey coreceptors. (A) HOS.CD4 cells stably expressing
rhesus and sooty mangabey CCR5 or CXCR4 were infected with HIV-1NL4-3 or SIVmac239 luciferase reporter viruses pseudotyped by various SIV
(mac1A11 and mac1A11rev), HIV-1 (JR-FL, ADA, and HXB2), or A-MuLV Envs (indicated in parentheses). Mac1A11rev contains the Rev coding
sequence in addition to Env. Luciferase activity was measured 4 days after inoculation. HOS.CD4 cells containing pBabe-puro (vector) were used to
control for expression of endogenous coreceptors. (B) U87.CD4 cells stably expressing SM-CCR5 or SM-CXCR4 were infected with the reporter
viruses as in A. HOS.CD4 cells supported some entry of T-tropic pseudotypes, possibly because of expression of endogenous CXCR4 or some other
unidentified coreceptor. When this experiment was repeated, similar results occurred.
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than 95% of PM1 cells expressed CCR5 (data not
shown). Both cell lines expressed high-level CXCR4
(more than 92%). With an equal virus input (p27 5 10
ng) in CEMx174 cells, SIVmac239 and SIVmac251 rep-
licated robustly within 2 days of infection, while no
detectable amount of p27 was found in SIVsmSL92b
cultures up to 10 days postinoculation (Fig. 3). In
contrast, PM1 cells supported the productive replica
tion of the SIVsmSL92b. It is likely that the low infec-
tivity of SIVsmSL92b on CEMx174 is due to the failure
of the virus to efficiently use BOB or other coreceptors
on CEMx174 cells. When the SIVsmSL92b input was
increased to 20 ng, the p27 antigen was detectable by
p27 assay 7 days after infection. These findings show
that SIVsmSL92b uses CCR5 on PM1 cells more effi-
ciently than the coreceptors on CEMx174 cells. A sim-
ilar viral replication kinetic was observed with
SIVsmFNS (Fig. 3).
Coreceptor usage of four primary HIV-2 isolates. It has
been proposed that HIV-2 originated from SIV naturally
TABLE 1
Coreceptor Usage of Primate Lentiviruses in HOS.CD4 or GHOS.CD4 Cells Expressing Various Chemokine Receptors
Virus
HOS.CD4
Human Sooty Mangabey Macaque
CCR5 CXCR4 BOBa Bonzoa CCR5 CXCR4 CCR5 CXCR4
TCLA SIVsmb
SL92a 11 2 11 1 11 2 11 2
Lib-1 11 2 11 11 11 2 11 2
SIVmac
239(nef open)/5593 11 2 11 1 11 2 11 2
251 11 2 11 1 11 2 11 2
316EM 11 2 11 1 11 2 11 2
HIV-1
JR-FL 11 2 2 2 11 2 11 2
Note. 2, no virus growth; 11, p27 . 2 ng/ml; and 1, 0.1 , p27 , 2 ng/ml at the peak; virus growth determined at days 4, 7, and 10 postinfection.
a Expressed in GHOS.CD4 cells.
b Stocks replicated in CEMx174 cells and MT-2 cells.
TABLE 2
Coreceptor Usage of Primary SIVsm and HIV-2 as Well as SIVmac from Macaques with AIDS in HOS.CD4
or GHOS.CD4 Cells Expressing Various Chemokine Receptors
Virus
Human Sooty Mangabey Macaque
CCR5 CXCR4 BOBa Bonzoa CCR5 CXCR4 CCR5 CXCR4
Primary SIVsm
SL92b 11 2 11 1 11 2 11 2
FNS 11 2 11 11 11 2 11 2
Primary HIV-2
A195811 11 2 11 11 11 2 11 2
A227011 11 2 11 11 11 2 11 2
G0415k 11 2 11 1 11 2 11 2
SIVmacb
251/1390 11 2 11 1 11 2 11 2
251/1434 11 2 11 1 11 2 11 2
239/5685 11 2 11 1 11 2 11 2
239/5501 11 2 11 1 11 2 11 2
Note. 2, no virus growth; 11, p27 . 2 ng/ml; and 1, 0.1 , p27 , 2 ng/ml at the peak; virus growth was determined at days 4, 7, and 10
postinfection.
a Expressed in GHOS.CD4 cells.
b SIVmac strains were isolated from macaques at their end stage of AIDS.
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harbored by sooty mangabeys through cross-species
transmission (Chen et al., 1996; Gao et al., 1994). If true,
identification of HIV-2 coreceptor usage may help in
understanding viral phenotypic variations and adapta-
tions. Four primary HIV-2 strains were tested. All four
strains were isolated from West Africans in the similar
time period that we isolated SIVsm and in the same
geographic regions (Chen et al., 1996; Gao et al., 1994).
It was shown that three HIV-2 isolates (A195811, A227011,
and G0415k) from asymptomatic individuals used CCR5,
replicated in human PBMC with a delta 32-bp homozy-
gous deletion and infected cells expressing BOB or
Bonzo (Tables 2 and 3). Because these results are sim-
ilar to those we found with SIVsm, it is likely that the
coreceptor tropism of SIVsm-like viruses remained the
same after being transmitted into humans. However, one
HIV-2 strain, 7924A, was only xR4-tropic. This virus was
the only isolate obtained from a West African with AIDS,
which suggests that the R5 HIV-2 may switch to CXCR4
in vivo, a phenomenon that has been observed in some
HIV-1-infected individuals (Connor et al., 1997). This find-
ing contrasts with those from SIVsm in that none were
xR4-tropic. HIV-27924A coreceptor usage was not char-
acterized on BOB and Bonzo, because the virus infected
the parental HOS.CD4 cells, which would interfere with
data interpretation.
Primary SIVsm strains use CCR5 in a CD4-dependent
pathway for productive infection. Some HIV-2 and neuro-
tropic SIV strains have been shown to use CXCR4 and
CCR5 in a CD4-independent fashion (Reeves and
Schulz, 1997; Edinger et al., 1997b). To test for CD4-
independent viral entry by primary SIVsm and primary
HIV-2, a subclone of the HOS cell line that expressed
Rh-CCR5 was generated. The expression levels of
Rh-CCR5 in this cell line were evaluated by FACS
analysis using monoclonal antibody 2D7 for cell stain-
ing. More than 70% of the cells expressed CCR5 on
their surface, similar to HOS.CD4.Rh-CCR5 cells (data
not shown). One pseudovirus complemented with
SIVmac1A11-Env could enter HOS.Rh-CCR5, but was
more than 10-fold less efficient than in entering
HOS.CD4.Rh-CCR5 (Figs. 4B and 4F). As we previously
determined, HOS.CD4 cells do not allow SIVmac entry;
neither do HOS.CD4.Rh-CXCR4 cells. These findings
suggest that mac1A11-Env may mediate CD4-indepen-
dent entry, but this entry was significantly enhanced
by the presence of CD4. In contrast, SIVmac239 and
SIVmne Env-based pseudoviruses did not enter
HOS.Rh-CCR5 sufficiently for infection. As has previ-
ously been found (Deng et al., 1997), GHOS.CD4.Hu-
BOB and GHOS.CD4.Hu-Bonzo supported entry of cer-
tain SIVmac-based pseudoviruses (Figs. 4D and 4E).
To test whether CCR5 alone is sufficient for primary
SIVsm and HIV-2 infection, cell-free viruses were used
to infect the HOS.Rh-CCR5 cells. Primary PBMC-de-
rived SIVsm strains could not productively infect the
cells in the absence of CD4 (Fig. 5). In contrast, pri-
mary brain-derived SIV strains, which are primary with
respect to the Rhesus macaque, have been reported to
use CCR5 independent of CD4 (Edinger et al., 1997b).
Although SIVmac316EM, SIVmac251, and HIV-
2A195811 grew in HOS.Rh-CCR5, the infection was
about 10-fold less efficient than when grown in
HOS.CD4-RhCCR5 at 10 days after infection. Thus,
TABLE 3
Coreceptor Usage of Primary SIVsm and HIV-2 and SIVmac Strains in U87.CD4 Cells or PBMC Expressing Various Chemokine Receptors
Virus
U87.CD4 PBMC
Human Sooty Mangabey Macaque Human
CCR5 CXCR4 CCR5 CXCR4 CCR5 CXCR4 ccr52/ccr52 Wild type
Primary SIVsm
SL92b 11 2 11 2 11 2 11 11
FNS 11 2 11 2 11 2 11 11
Primary HIV-2
A195811 11 2 11 2 11 2 11 11
A227011 11 2 11 2 11 2 11 11
G0415k 11 2 11 2 11 2 11 11
7924A 2 11 2 11 2 11 11 11
SIVmaca
251/1390 11 2 11 2 11 2 11 11
251/1434 11 2 11 2 11 2 11 11
239/5685 11 2 11 2 11 2 11 11
239/5501 11 2 11 2 11 2 11 11
Note. Labels are the same as in Table 2.
a SIVmac strains were isolated from macaques at the end stage of AIDS.
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most of the SIV and HIV-2 strains tested, including
primary SIVsm strains, required CD4 for productive
infection. Interestingly, both SIVmac316EM and SIV-
mac251 were macrophage competent. As it has been
shown that macrophage competent SIV uses CCR5 in
a way that differs from non-M-tropic SIVmac239
(Edinger et al., 1997a), the CD4-independent usage of
CCR5 might be determined by SIVmac Envs.
Use of CCR5 but not CXCR4 by SIVmac strains isolated
from macaques with AIDS. To test whether a CXCR4
phenotypic switch is required during AIDS development
in macaques, four SIVmac strains were isolated from
macaques at the end stages of AIDS. Two animals,
Rh1390 and Rh1434, had been intravaginally challenged
with a parental stock of SIVmac251 and developed AIDS
after inoculation (Marx et al., 1996). The new isolates,
SIVmac251/1390 and SIVmac251/1434, were obtained
from PBMC of these animals collected at the time of
euthanasia with AIDS. Two other macaques, Rh5685 and
Rh5501, were intravaginally challenged with a parental
stock of SIVmac239(nef open)/5593 in a SIVmac-trans-
mission study (Sodora et al., 1998). Similarly, we isolated
SIVmac239/5685 and SIVmac239/5501 from PBMC of
these macaques collected before necropsy. Like their
parental strains, all four isolates used human or simian
CCR5 (Tables 2 and 3) but not human or simian CXCR4.
Therefore, it is likely that CXCR4 is not required for AIDS
development in the SIV macaque model. Moreover, when
we tested the effect of these four isolates on HOS.Rh-
CCR5 cells using the p27 assay, viral infection was not
detected, suggesting that all four viral strains use CCR5
in a CD4-dependent way (Fig. 5). Because parental SIV-
mac251 infected HOS.Rh-CCR5 cells, the failure of SIV-
mac251/1390 and SIVmac251/1434 to infect the same
cells indicates a phenotypic change after intravaginal
transmission. Finally, as with their parental viruses, all
SIVmac239- and SIVmac251-derived strains strongly
used BOB for productive infection. In contrast, replication
as measured by p27 was low in Bonzo-expressing cells.
Therefore, the findings suggest that CCR5 and BOB are
major coreceptors for SIVmac. SIVmac used these core-
ceptors from the time of virus transmission and did not
change coreceptor usage during progression to disease
for 1 to 2 years.
FIG. 3. Replication of primary SIVsm in PM1 (A) and CEMx174 (B) cells. The amount of p27 contained in the inoculum is indicated for each SIV strain.
HIV-1JR-Fl and HIV-1NL4-3 (500 TCID50 each) are included as controls. A portion of the supernatant was collected on days 0, 3, 7, and 10 for p27/p24
antigen measurement. Each point is the average of duplicate measurements. SIVsmSL92b (10 ng), SIVsmFNS (10 ng), and HIV-1JR-FL were all
negative for growth in CEMx174 cells (B).
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DISCUSSION
We and others previously showed that lentiviruses
isolated from sooty mangabeys (SIVsm) use human and
rhesus CCR5 as a coreceptor for infection (Chen et al.,
1997). However, the role of CCR5 and its polymorphism
on SIVsm in its natural hosts was not studied and the
coreceptor usage of primary SIVsm strains remained
unclear. To better understand the function of CCR5
genes of sooty mangabeys, we focused on four wild
animals that were originally found among a group of
free-ranging nonhuman primates in Sierra Leone in 1992.
Importantly, all four animals were naturally infected with
SIVsm, which consisted of a group of genetically diver-
gent viruses within the SIVsm/HIV-2 family (Chen et al.,
1996). We now demonstrate that CCR5 and CXCR4 de-
rived from these sooty mangabeys are highly homolo-
gous (97–99%) with those from human and macaque.
Both SM-CCR5 and SM-CXCR4 function as coreceptors
for primate lentiviruses, and two primary SIVsm strains
use CCR5, BOB, and Bonzo for infection.
SM-CCR5 functions as a coreceptor for SIVsm, includ-
ing the two primary isolates tested. When the SM-CCR5
genes of different feral mangabeys were compared with
human counterparts, several amino acid substitutions
were identified. Because a single amino acid substitu-
tion completely blocked the coreceptor function for M-
tropic HIV-1 in a CCR5 gene derived from an African
green monkey (Kuhmann et al., 1997), it was important to
know if the changes in the SM-CCR5 genes have a
similar effect. We found that all four SM-CCR5 proteins
are active in vitro. They facilitate the entry or infection of
SIVsm, SIVmac, HIV-2, and M-tropic HIV-1 strains, includ-
ing SIVsmSL92a, which was isolated from one of four
wild mangabeys (Chen et al., 1995). As the viral pheno-
type may differ between primary and TCLA viruses, we
further tested the coreceptor usage of two primary SIVsm
strains. Both viruses used SM-CCR5 but not SM-CXCR4.
That CCR5 is used by primary SIVsm strains lends fur-
ther support for the central role of this chemokine recep-
tor in SIVsm-infected natural hosts.
CCR5 is likely a major coreceptor for the natural trans-
mission of SIVsm in sooty mangabeys. In this study,
primary SIVsm strains readily infected PM1 cells, which
express CCR5, but not CEMx174 cells, which do not.
Compared with SIVmac strains, primary SIVsm appeared
to require adaptation in order to grow on CEMx174 cells.
This adaptation process may be due to the use of core-
ceptors other than CCR5 on CEMx174 cells. This possi-
bility is supported by the following: (1) when virus input
was increased, both primary SIVsm strains replicated
with delayed kinetics in CEMx174 cells in the absence of
CCR5; and (2) both primary SIVsm strains used BOB,
which is a new coreceptor identified recently on
CEMx174 cells (Deng et al., 1997). Hence, although BOB
may serve as a coreceptor after viral adaptation, CCR5
appears to be a more efficient coreceptor for primary
SIVsm transmission.
SM-CXCR4 from sooty mangabeys also functions as a
viral coreceptor for HIV-1. Because SIVsm-derived vi-
ruses do not use CXCR4 as a coreceptor, it may be that
the sooty mangabey, the natural viral host, may have
defects in its CXCR4 gene; the virus, therefore, could not
switch to use CXCR4 during viral transmission and evo-
lution. To test this possibility, we amplified by RT-PCR a
CXCR4 gene from the PBMC of an uninfected sooty
mangabey and found it contained 11 amino acid substi-
tutions compared to its human counterpart. These sub-
stitutions, however, did not change its function as a viral
coreceptor. U87.CD4 cells, which do not express endog-
enous CXCR4, supported infection by both CXCR4-spe-
cific HIV-1 and HIV-2 but not by a panel of SIVsm/mac or
three primary HIV-2 strains tested. Therefore, the failure
FIG. 4. Entry of luciferase reporter viruses into seven cell lines. The activity of SIVmac luciferase reporter viruses pseudotyped by various SIV
(mac1A11, mac239 and mne) or A-MuLV Envs (indicated in parentheses) was measured 4 days after inoculation into (A) HOS, (B) HOS.Rh-CCR5, (C)
HOS.CD4, (D) GHOS.CD4.Hu-BOB, (E) GHOS.CD4.Hu-Bonzo, (F) HOS.CD4.Rh-CCR5, and (G) HOS.CD4.Rh-CXCR4 cells.
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of SIVsm to use CXCR4 is probably not due to an intrinsic
CXCR4 gene defect in sooty mangabeys. Moreover, our
results suggest that SM-CCR5 and SM-CXCR4 do not
restrict HIV infection of sooty mangabeys. The block of
HIV-1 infection in mangabey cells must be postentry.
The similar coreceptor tropism between primary HIV-2
and SIVsm suggests their common origin. Phylogenetic
analysis revealed that HIV-2 might originate from SIV
naturally harbored by sooty mangabeys through cross-
species transmission events. Because HIV-2 isolates
group tightly with SIVsm within the primate lentiviral
family (Chen et al., 1996; Gao et al., 1994), sooty manga-
beys are most probably the only natural hosts carrying
the HIV-2-like lentiviruses. However, HIV-2 isolates have
been shown to use CCR5, CXCR4, or both (Endres et al.,
1996; Lu et al., 1997; Pleskoff et al., 1997). Moreover,
some HIV-2 strains efficiently use CXCR4 for virus entry
in a CD4-independent fashion (Endres et al., 1996;
Reeves and Schulz, 1997). To further understand the
phenotypic similarity between primary SIVsm and pri-
mary HIV-2, four primary HIV-2 strains were tested on
stable cell lines expressing different coreceptors. Inter-
estingly, like primary SIVsm strains, three of the four
primary HIV-2 strains shared the same coreceptor use
on CCR5 or BOB. This result indicates that the corecep-
tor usage of primary HIV-2 obtained from asymptomatic
individuals is similar to that of primary SIVsm and that
the viruses therefore retain their ability to use several
coreceptors after adaptation to humans. This property
also holds for SIVmac isolates obtained from Asian ma-
caques, as SIVmac used both CCR5 and BOB. Unexpect-
edly, the fourth primary HIV-2 strain, 7924A, used CXCR4
but not CCR5 as a coreceptor. Because 7924A was the
only isolate obtained from an AIDS patient, the results
suggest that the CXCR4 tropism of HIV-2 might not result
from the adaptation of the virus in human T-cell lines in
vitro but rather from AIDS development in humans. Our
findings agree with a recent study showing that two
primary HIV-2 isolates from AIDS patients use CXCR4
(Sol et al., 1997).
CXCR4 usage was not required for AIDS develop-
ment in SIVmac-infected macaques. In some infected
FIG. 5. Replication of primary SIVsm and HIV-2 strains on (A) HOS.Rh-CCR5 and (B) HOS.CD4.Rh-CCR5 cells. The virus input was 5–10 ng/well of
p27 for SIVsm and SIVmac strains and 500 TCID50 for primary HIV-2 strains. A portion of the supernatant was collected on days 0, 4, 7, and 10 for
p27 antigen measurement.
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humans, HIV-1 tropism changes with disease progres-
sion (Zhu et al., 1993). During the early phase of
infection, virus isolates are typically M-tropic, whereas
they tend to be T-tropic late in the disease. It has been
hypothesized that this phenomenon, the so-called
‘‘phenotypic switch,’’ results from an expansion of co-
receptor usage from CCR5 to CXCR4 or other chemo-
kine receptors (Connor et al., 1997). These findings
together with our demonstration that HIV-27924A uses
CXCR4 suggest that an analogous coreceptor switch
or expansion may also exist in simian AIDS models.
Therefore, the coreceptor usage of four SIVmac strains
isolated from macaques with AIDS was further tested.
The coreceptor tropism of two separate challenge
stocks, SIVmac239(nef open)/5593 and SIVmac251,
was characterized. Previous studies showed that
these two viruses use CCR5 but not CXCR4. We now
find that these two viruses also use BOB. Interestingly,
all four SIVmac strains derived from macaques with
AIDS continued to use CCR5 and BOB but not CXCR4.
Hence, CXCR4 usage is not strictly required for AIDS
development in SIV-infected macaques. The genotypic
variation of SIVmac239 after intravaginal challenge
was previously characterized. Notably, 120 days after
infection, both SIVmac239/5685 and SIVmac239/5501
exhibited distinct genotypes in comparison to their
parental stock, SIVmac239(nef open)/5593 (Sodora et
al., 1998). These genotypic changes, however, did not
alter coreceptor use. This result suggests that the
genotypic variation during disease progression may
not necessarily affect coreceptor tropism in macaques
with AIDS.
MATERIALS AND METHODS
Virus stocks. The preparation of virus stocks has been
previously described (Chen et al., 1997). The virus stocks
include (i) SIVmac239/316EM; (ii) SIVmac239(nef open)/
5593; (iii) SIVmac251; (iv) SIVsmSL92a; and (v) SIVsmLib-1.
M-tropic (JR-FL) and T-tropic (NL4-3) HIV-1 strains were
used to demonstrate appropriate coreceptor expression on
each cell type.
Four primary HIV-2 strains (kindly provided by Dr. Bea-
trice Hahn) (Gao et al., 1994) were originally isolated from
West Africans and were propagated and titered in human
PBMC in our laboratory.
Four SIVmac strains, SIVmac239/5685, SIVmac239/
5501, SIVmac251/1390, and SIVmac251/1434, were ob-
tained from macaques that developed AIDS (Marx et al.,
1996; Sodora et al., 1998). These viruses were isolated
and propagated in rhesus PBMC.
Luciferase reporter viruses were prepared by cotrans-
fecting 293T cells with pNL-Luc-Env2 or pSIV-Luc-R2E2
and vectors expressing different SIV or HIV-1 Envs, as
previously described (Deng et al., 1996).
Cells. Sooty mangabey, rhesus monkey, and human
PBMC were prepared by Ficoll gradient separation, as
previously described (Chen et al., 1995). Human osteo-
sarcoma HOS.CD4 and glioma U87.CD4 cells, which
stably express primate chemokine receptors and CD4,
have been described previously (Chen et al., 1997).
GHOS.CD4 cells are HOS.CD4-derived cells expressing
green fluorescence protein. GHOS.CD4.Hu-BOB and
GHOS.CD4.Hu-Bonzo were kindly provided by Dr. Dan
Littman at New York University Medical Center. Genera-
tion of CEMx174, a T-B-cell hybrid cell line, and PM1, a
transformed T-cell line, have also been previously de-
scribed (Lusso et al., 1995).
Isolat ion of pr imary SIVsm. A primary SIVsm,
SIVsmSL92b, was isolated from a household pet sooty
mangabey in Sierra Leone (Chen et al., 1996). To prepare
stocks of primary viruses, uninfected sooty mangabey
PBMC were obtained from the Yerkes Regional Primate
Research Center (Atlanta, GA) and used for isolation and
propagation of the virus from the PBMC of the original
mangabey host. Therefore, primary SIVsmSL92b was
never passaged in another animal species nor in human
cell lines. The donor mangabey’s PBMC were cultured in
interleukin-2 and ConA-containing growth medium. For-
ty-eight hours after stimulation, 106 donor PBMC were
mixed with an equal amount of PBMC from the naturally
infected mangabey. The viral replication was measured
by a commercial p27 kit (Cellular Products, Buffalo, NY).
A second primary isolate, SIVsmFNS, was kindly given
by Dr. Frank Novembre (Yerkes Regional Primate Cen-
ter). SIVsmFNS was originally isolated from a captive
sooty mangabey (FNS) at that Center and then propa-
gated in sooty mangabey PBMC as described above.
Plasmid construction and expression of SM-CCR5 and
SM-CXCR4. The procedure for constructing expression
plasmids has been previously described for rhesus
CCR5 and CXCR4 (Chen et al., 1997). Briefly, virus stocks
for the retroviral vectors expressing CCR5 and CXCR4,
pBabe/CCR5 and pBabe/CXCR4, respectively, were pre-
pared by transfecting 293T cells with the MuLV-gag/pol
vectors pSV-psi-MLV-env2 and pcVSV-G. Virus was har-
vested 48 h after transfection and frozen at 270°C.
HOS.CD4 and U87.CD4 were infected with 2 ml of the
pBabe virus and were selected 48 h later in culture
medium containing 1.0 mg/ml puromycin (Sigma, St.
Louis, MO). Puromycin-resistant cells were then used in
an HIV-1 and SIV Env-mediated syncytium formation as-
say and for infection with replication-competent or lucif-
erase reporter viruses. To test viral CD4 dependence on
Rh-CCR5, stable HOS.Rh-CCR5 cells were made by in-
fecting HOS cells with the pBabe/Rh-CCR5 virus.
Virus entry assay. To test for viral entry, cells (2 3 104
to 3 3 104) were seeded in 24-well dishes in culture
medium and infected with luciferase reporter virus (20 ng
p24 or p27) in a total volume of 300 ml containing 1 ng/ml
polybrene. After incubation overnight, 1 ml of medium
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was replaced in each well. After 3 additional days of
culture, 100-ml lysates were prepared and luciferase ac-
tivity in 20 ml was measured using commercially avail-
able reagents (Promega, Madison, WI).
Infectivity assays. To determine coreceptor usage of
different viruses, HOS.CD4 or U87.CD4 cells (2 3 104)
stably expressing human or rhesus coreceptors were
seeded in 24-well plates. The next day the cells were
infected with 5–10 ng/ml of SIV or 500 TCID50 of HIV-1.
After 12 h, input virus was removed by replacing the
medium three times. The cells were maintained with low
serum (2% fetal calf serum) medium for up to 10 days.
Virus production was measured by harvesting aliquots of
each supernatant and measuring p27 (Cellular Products)
or p24 (Abbot, Chicago, IL) by ELISA. After removing 0.5
ml culture supernatant per well for assay, the same
amount of fresh medium was added to the culture.
To test viral kinetics in CEMx174 or PM1 cells, 1 3 106
cells were seeded in each of the 24 wells per plate. After
12 h, input virus was removed by replacing the culture
medium three times. Viral replication was measured as
described above.
Fluorescence-activated cell sorting (FACS) analysis.
Two monoclonal antibodies, 2D7 for CCR5 and 12G5 for
CXCR4, were kindly provided by Drs. Charles Mackay
and James Hoxie, respectively. PE-labeled secondary
antibodies were obtained from CALTAG Laboratories.
PE-anti-CD4 antibodies were from Becton Dickinson.
These reagents were used to access the expression of
CD4, CCR5, and CXCR4 on various cell lines. The stain-
ing procedure was done according to the manufacturer’s
instructions.
Sequence analysis. The sequences of chimpanzee
and sooty mangabey CCR5 and CXCR4 were determined
using an automated sequencer (ABI Prism 377 DNA
sequencer). At least two molecular clones were se-
quenced from each animal using overlapping primers.
The sequences of SM-CCR5 and SM-CXCR4 have been
submitted to GenBank.
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